Ophthalmology – Page 8

Oral Lamivudine: A Promising Alternative in the Management of Diabetic Macular Edema

By MedXY 09/17/2025

A recent randomized, double-blind trial demonstrates that oral lamivudine significantly improves visual acuity in patients with center-involved diabetic macular edema, offering a cost-effective and safer alternative to conventional anti-VEGF therapy.

AI news Ophthalmology Specialties

Deep Learning Prediction of Retinal Nerve Fiber Layer Thickness as a Novel Risk Biomarker for Glaucoma in Ocular Hypertension

By MedXY 09/12/2025

A novel deep learning model predicted retinal nerve fiber layer thickness from optic disc photos, enabling risk stratification for primary open-angle glaucoma in ocular hypertension patients, with baseline and longitudinal changes strongly correlated with disease conversion.

AI Ophthalmology Specialties

Deep Learning Predicts Glaucoma Risk via Retinal Nerve Fiber Layer Thickness from Ocular Hypertension Photographs

By MedXY 09/12/2025

Deep learning models predicting RNFL thickness from optic disc photographs can identify ocular hypertension patients at higher risk for primary open-angle glaucoma, enhancing early risk assessment and monitoring disease progression.

Clinical Updates news Ophthalmology Specialties

Diversified Segmental Defocus Optimization Lenses With and Without Atropine: A New Frontier in Myopia Prevention

By MedXY 09/11/2025

A recent randomized clinical trial demonstrates that diversified segmental defocus optimization (DSDO) spectacle lenses significantly reduce the onset and progression of myopia in children, with or without adjunct low-dose atropine.

Clinical Updates news Ophthalmology Specialties

Low-Level Light Therapy: A New Frontier in Preventing Dry Eye After Cataract Surgery

By MedXY 09/01/2025

Low-level light therapy, administered perioperatively, significantly reduces dry eye symptoms and preserves ocular surface integrity after cataract surgery, offering a noninvasive adjunct to standard care.

Ophthalmology Public Health Specialties

Michigan’s MI-SIGHT Telemedicine Program: Enhancing Glaucoma Screening, Vision Outcomes, and Cost-Effectiveness in Underserved Communities

By MedXY 08/24/2025

The MI-SIGHT telemedicine program significantly improves vision and eye health outcomes by providing glaucoma and eye disease screening with care navigation in community health centers, demonstrating high satisfaction and cost-effectiveness in underserved populations.

AI Medical News news Ophthalmology Specialties

Japan’s Bold Move: Limiting Daily Smartphone Use to Protect Eye Health and Well-being

By MedXY 08/23/2025

Japan’s Aichi Prefecture proposes a new ordinance limiting daily smartphone use to two hours, citing research that excessive social media use causes eye fatigue and physiological distress, especially among youth.

Family Medicine & Nutrition news Ophthalmology Specialties

Influence of Sleep, Physical Activity, and Sedentary Behavior on Cataract Risk: Insights from the UK Biobank Study

By MedXY 08/21/2025

A large UK Biobank study demonstrates that poor sleep, low physical activity, and high sedentary behavior independently and jointly increase cataract risk, with lifestyle modifications reducing incidence.

Clinical Updates Diabetes & Endocrinology news Ophthalmology Specialties

Long-Term Metformin Use Linked to Reduced Risk of Age-Related Macular Degeneration in Diabetic Patients

By MedXY 08/17/2025

A large retrospective study found that diabetic patients using metformin for at least five consecutive years have a significantly lower risk of developing age-related macular degeneration, especially the dry type.

Clinical Updates news Ophthalmology Specialties

Decoding the Blink: How Segmental Control of the Orbicularis Oculi Could Enable Blink Neuroprostheses

By MedXY 08/09/2025

UCLA engineers and ophthalmologists mapped segmental, task-dependent activation of the orbicularis oculi during five closure behaviors, defining a roadmap for targeted neurostimulation to restore protective blinking in patients with eyelid paralysis.

Clinical Updates news Ophthalmology Specialties

Alcon’s Tryptyr: A New Neuromodulatory Approach for Rapid Dry Eye Relief

By MedXY 08/02/2025

Alcon introduces Tryptyr, the first TRPM8 agonist eye drop, promising rapid tear production for dry eye disease. FDA-approved in May 2024 following robust phase 3 trials.

Clinical Updates news Ophthalmology Specialties

FDA Approves Once-Daily Vizz (Aceclidine Ophthalmic Solution 1.44%) for Presbyopia: Clinical Implications and Evidence Review

By MedXY 08/02/2025

The FDA has approved Vizz, a once-daily aceclidine ophthalmic solution, for presbyopia in adults based on robust phase 3 data. The eye drop offers up to 10 hours of improved near vision with a favorable safety profile.

Clinical Updates Diabetes & Endocrinology news Ophthalmology Specialties

Veligrotug Emerges as a Promising Therapy for Thyroid Eye Disease: Insights from the THRIVE and THRIVE-2 Trials

By MedXY 07/31/2025

Veligrotug demonstrates robust efficacy and manageable safety in both active and chronic thyroid eye disease, positioning itself as a potential alternative to teprotumumab based on phase 3 THRIVE trial data.

Clinical Updates news Ophthalmology Otorhinolaryngology Specialties

GLP-1 Receptor Agonists Linked to Early Risk of Optic Nerve Damage: A Case-Control Study Analysis

By MedXY 07/30/2025

GLP-1 receptor agonist use, especially liraglutide, is associated with a higher risk of nonarteritic anterior ischemic optic neuropathy (NAION) during the first year, particularly in patients without diabetes or obesity.